RecruitingNot ApplicableNCT07380412

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications


Sponsor

Outliers, Inc.

Enrollment

90 participants

Start Date

Aug 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria8

  • Aged 18-55 years
  • Currently prescribed stimulant medication for ADHD
  • Experiencing: sleep difficulty, irritability, anxiety, brain fog
  • Stable medication dose ≥3 months
  • Healthy with no uncontrolled chronic conditions
  • Stable on supplements ≥3 months if applicable
  • US resident
  • Willing to maintain current habits

Exclusion Criteria7

  • Chronic conditions (e.g. cancer, mental illness)
  • Use of psychiatric medications besides stimulants
  • Pregnancy, breastfeeding, thyroid, liver, kidney conditions
  • Recent smokers or heavy alcohol use
  • Night shift workers
  • Participation in other clinical trials
  • Allergies to product ingredients

Interventions

DIETARY_SUPPLEMENTStasis Daytime and Nighttime

Daytime taken with stimulant medication and food. Nighttime taken 30 minutes before bedtime on an empty stomach.

DIETARY_SUPPLEMENTPlacebo

Matched placebo product in taste and appearance.


Locations(1)

Citruslabs

Las Vegas, Nevada, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07380412


Related Trials